Severe Short Stature in an Adolescent Male with Prader-Willi Syndrome and Congenital Adrenal Hyperplasia: A Therapeutic Conundrum

  • Wasserman M
  • Mulvihill E
  • Ganan-Soto A
  • et al.
N/ACitations
Citations of this article
16Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency results in excess androgen production which can lead to early epiphyseal fusion and short stature. Prader-Willi syndrome (PWS) is a genetic disorder resulting from a defect on chromosome 15 due to paternal deletion, maternal uniparental disomy, or imprinting defect. Ninety percent of patients with PWS have short stature. In this article we report a patient with simple-virilizing CAH and PWS who was overtreated with glucocorticoids for CAH and not supplemented with growth hormone for PWS, resulting in a significantly short adult height.

Cite

CITATION STYLE

APA

Wasserman, M., Mulvihill, E. M., Ganan-Soto, A., Uysal, S., & Quintos, J. B. (2017). Severe Short Stature in an Adolescent Male with Prader-Willi Syndrome and Congenital Adrenal Hyperplasia: A Therapeutic Conundrum. Case Reports in Endocrinology, 2017, 1–4. https://doi.org/10.1155/2017/4271978

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free